Ketogenic Diet Health and Longevity (KDHL)
Ketogenic Dieting, Ketoses, Metabolic, Ketosis
About this trial
This is an interventional prevention trial for Ketogenic Dieting focused on measuring ketogenic, well-formulated ketogenic diet, keto
Eligibility Criteria
Inclusion Criteria: 30 to 55 years Speaks English as primary language BMI 20.0-34.9 kg/m^2 Exclusion Criteria: Certain medications (statin, blood pressure, thyroid hormone replacement, etc.) Prior medical diagnosis of type 1 or type 2 diabetes mellitus, cancer requiring chemotherapy or radiation therapy within 5 years, cardiac event, GI disorders, traumatic brain injury/multiple concussions, hypertension, dyslipidemia, or any diagnosis deemed ineligible by study team History of renal stones Currently lactating Already following a ketogenic diet Adherence to a specialized diet regimen that disallows compliance Use of tobacco or tobacco replacement products within 1 year
Sites / Locations
- University of Kansas Medical Center
Arms of the Study
Arm 1
Experimental
Well-formulated ketogenic diet (WFKD)
The researchers aim to enroll 20 healthy adults recruited from Kansas City and surrounding areas for an 8-week WFKD diet intervention. Study personnel will obtain baseline (week 0), mid-point (week 4), and end-of-study (8 weeks) blood samples, anthropometrics, and dietary intake data. Fecal microbiome samples and dual energy x-ray absorptiometry (DXA) are collected at baseline and 8-weeks. Blood samples collected at baseline and 8-week visits will be measured for metabolic biomarkers, inflammatory biomarkers, and RNA. The blood sample collected at the 4-week visit will include glucose, insulin, insulin resistance, and beta-hydroxybutyrate to track diet adherence and adjust the diet as needed.